What is the recommended treatment for an Enterococcus faecalis wound infection in an adult without a β‑lactam allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Enterococcus faecalis Wound Infection

For an adult with an Enterococcus faecalis wound infection and no β-lactam allergy, ampicillin or amoxicillin is the first-line treatment, with dosing and duration dependent on infection severity and clinical response.

Primary Treatment Approach

For Susceptible E. faecalis (Most Common)

Ampicillin remains the drug of choice for E. faecalis infections, as approximately 82-97% of E. faecalis isolates remain susceptible to aminopenicillins, even among vancomycin-resistant strains 1, 2. This is critical because:

  • E. faecalis accounts for approximately 97% of enterococcal infections 3
  • Resistance mechanisms to vancomycin (vanA/vanB operons) are distinct from β-lactam resistance mechanisms (altered penicillin binding proteins), explaining preserved ampicillin susceptibility 2

Recommended Regimens by Severity

For uncomplicated wound infections:

  • Ampicillin 2 g IV every 4-6 hours, OR
  • Amoxicillin 500 mg PO/IV every 8 hours 4
  • Duration: 7-14 days depending on clinical response

For severe/complicated wound infections:

  • Ampicillin 2 g IV every 4 hours PLUS gentamicin 3 mg/kg/day IV in divided doses for synergy 3
  • Gentamicin should be limited to initial 2 weeks if used 3
  • This combination achieves bactericidal activity, as ampicillin alone is bacteriostatic against enterococci 3

Critical Susceptibility Testing

Before finalizing therapy, obtain:

  1. Ampicillin/penicillin MIC determination (Class I recommendation) 3
  2. High-level gentamicin resistance testing (≥500 μg/mL) if considering combination therapy 3, 5
  3. Vancomycin susceptibility to identify VRE 3

This is essential because if the strain shows high-level aminoglycoside resistance, the combination with gentamicin will not provide synergy and should be avoided 3.

Alternative Agents for Specific Scenarios

If Vancomycin-Resistant E. faecalis (VRE)

Despite vancomycin resistance, most VRE E. faecalis remain ampicillin-susceptible (82% in recent data) 2. Therefore:

  • First choice: Ampicillin (if susceptible) - no mortality observed in recent cohorts 2
  • Second choice: Linezolid 600 mg IV/PO every 12 hours (Strong recommendation) 4
  • Third choice: Daptomycin 8-12 mg/kg/day (for severe infections) 4

Important caveat: Despite ampicillin susceptibility, daptomycin is frequently overused for VRE E. faecalis (19% usage rate), representing an antimicrobial stewardship opportunity 2.

For Ampicillin-Resistant Strains

If truly ampicillin-resistant (uncommon in E. faecalis):

  • Vancomycin 30 mg/kg/day IV in 2 divided doses (target trough 10-20 μg/mL) 3
  • Linezolid 600 mg every 12 hours 4, 1
  • Tigecycline 100 mg loading, then 50 mg IV every 12 hours (for intra-abdominal sources) 4

Common Pitfalls to Avoid

  1. Overuse of broad-spectrum agents: Daptomycin and linezolid are frequently used empirically when ampicillin would suffice 2. Check susceptibilities promptly and de-escalate.

  2. Inappropriate aminoglycoside use: If high-level gentamicin resistance is present (increasingly common in surgical wards 5), adding gentamicin provides no benefit and only toxicity risk 3.

  3. Confusing colonization with infection: Enterococci frequently colonize wounds without causing true infection 4. Treat only when clinical signs of infection are present.

  4. Cephalosporin/quinolone exposure: Prior use of these agents is a major risk factor for enterococcal colonization and infection 6. Avoid empiric cephalosporins when enterococcal infection is suspected.

  5. Inadequate source control: For surgical wounds, ensure adequate debridement and drainage, as antibiotics alone may be insufficient.

Monitoring Parameters

  • Clinical response within 48-72 hours
  • Renal function if using aminoglycosides or vancomycin
  • Complete blood count if using linezolid (risk of bone marrow suppression) 3
  • CPK levels if using daptomycin (risk of myopathy) 2

Duration of Therapy

  • Uncomplicated wound infections: 7-14 days based on clinical response
  • Deep/complicated infections: Minimum 14 days, potentially longer
  • If bacteremia present: 14 days from first negative blood culture (longer if endocarditis excluded) 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.